Notably, mRNA expression levels of SP100 family members were consistently elevated in nine cancer tissues, including PAAD, cholangiocarcinoma (CHOL), and stomach adenocarcinoma (STAD), when compared to their respective noncancerous counterparts. This evidence concerns the gene SP100 and cancer.